top of page

Centre for
Immunology & Infection

C2i is the fruit of a long-standing partnership of over 20 years between the LKS Faculty of Medicine of the University of Hong Kong and the Institut Pasteur, dating back to the year 2000 with the creation of a joint laboratory in Hong Kong, named the HKU-Pasteur Research Pole.

These two leading institutions have combined their expertise to establish a translational research center with the overarching goal of delivering innovative interventions targeting infectious diseases to advance biomedical research at local and global scale. Our center is defined by our name – Immunology & Infection. 

C2i aims to characterize immune responses to infectious agents and their components in a healthy Asian population, develop new vaccine platforms and treatments for lethal respiratory virus infections, and set up new strategies to monitor mosquito-borne viruses.

An international team with multidisciplinary expertise  



1,000m2 facilities with state-of-the-art laboratories, including the only insectarium in Hong Kong for live mosquitoes  


Thriving in the dynamic environment offered by Science Park (HKSTP) to foster innovation  

Rebranding_Primary Logo_Black (1).png
Cheung Chin Lan Hong Artrium.jpg
logo_IP_noir_sur_blanc 2020.jpg

Using novel high-tech platforms for biomarker discovery and the development of new vaccine and therapeutic strategies

The four integrated programs of C2i address major unmet global and local public health needs and enhance Hong Kong’s knowledge-based economy, while providing state-of-the-art training for local staff. Ultimately, the outcomes are expected to advance health by improving the effectiveness of future public health initiatives.

With the creation of C2i, we are building a strong team of world-class scientists who leverage the international expertise and networks of two of the most renowned institutions in the field of biomedical research. 

C2i is managed by a team of international experts with the ambition to make Hong Kong a global center of excellence for precision medicine population strategies and innovative interventions targeting emerging infectious diseases.

A team dedicated to generating biological knowledge to accelerate the understanding and treatment of infectious diseases with a common goal: IMPROVE GLOBAL HEALTH

C2i Management Photo December 2023 -.jpg
INNOHK logo.png
  • Threads
  • YouTube
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
bottom of page